Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Dis ; 187(7): 1053-63, 2003 Apr 01.
Article in English | MEDLINE | ID: mdl-12660919

ABSTRACT

Eighteen highly exposed but persistently seronegative (HEPS) women (HW) and their human immunodeficiency virus (HIV) type 1-seropositive male partners were studied for HIV-specific T cells and other host factors. Circulating HIV-specific T cells were measured by interferon-gamma enzyme-linked immunospot assays, using recombinant vaccinia virus vectors expressing HIV proteins. Nine (50%) of the HW and all HIV-seropositive persons had HIV-specific T cell responses. Only 2 (22%) of the HEPS responders recognized Env, compared with 94% of HIV-seropositive persons. A high percentage (75%) of the HW with HIV-specific T cell responses reported recent HIV exposure. Remarkably, however, long-lived HIV-specific T cells were detected in 2 HW who had an extended period (>3.9 years) of no HIV exposure. These findings have important implications for HIV vaccine design.


Subject(s)
HIV Antigens/immunology , HIV Infections/immunology , HIV Seronegativity/immunology , HIV-1/immunology , T-Cell Antigen Receptor Specificity/immunology , T-Lymphocytes/immunology , AIDS Vaccines , Adult , Female , Gene Products, env/genetics , Gene Products, env/immunology , HIV Antigens/genetics , HIV Infections/transmission , HIV-1/genetics , Humans , Male , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...